IGI Laboratories, Inc. We are a formulation company engaged in the contract development, manufacturing, filling and packaging of topical, semi-solid products for cosmetic, cosmeceutical, and pharmaceutical customers. The company’s strategic plan is to continue to build upon this foundation by expanding into the prescription pharmaceutical arena. This strategy is based upon three initiatives: increasing the current Contract Services business, developing a generic portfolio of formulations in topical dosage forms, and creating unique opportunities around the company’s licensed Novasome® technology and novel dosage forms.